0001062993-24-012192.txt : 20240607 0001062993-24-012192.hdr.sgml : 20240607 20240607162951 ACCESSION NUMBER: 0001062993-24-012192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saadi Ryan H. CENTRAL INDEX KEY: 0002011728 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41002 FILM NUMBER: 241029985 MAIL ADDRESS: STREET 1: C/O TEVOGEN BIO HOLDINGS INC. STREET 2: 15 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tevogen Bio Holdings Inc. CENTRAL INDEX KEY: 0001860871 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981597194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 INDEPENDENCE BOULEVARD, SUITE 410 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 646-807-8832 MAIL ADDRESS: STREET 1: 15 INDEPENDENCE BOULEVARD, SUITE 410 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Semper Paratus Acquisition Corp DATE OF NAME CHANGE: 20210505 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-06-05 0001860871 Tevogen Bio Holdings Inc. TVGN 0002011728 Saadi Ryan H. C/O TEVOGEN BIO HOLDINGS INC. 15 INDEPENDENCE BLVD, SUITE 410 WARREN NJ 07059 1 1 1 0 Chief Executive Officer 0 Common Stock 2024-06-05 4 P 0 2607.322 0.7671 A 118252659.322 D Common Stock 193924 I By wife The price reported in Column 4 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7635 to $0.7671, inclusive. The reporting person undertakes to provide to Tevogen Bio Holdings Inc., any security holder of Tevogen Bio Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ Kirti Desai, Attorney-in-Fact 2024-06-07